Business Context and Reporting Period
This Form 8-K Current Report was filed by Humana Inc. on April 10, 2026. The report addresses corporate governance changes effective immediately following the adjournment of the Company's 2026 Annual Meeting of Stockholders on April 16, 2026.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on the appointment of a new director and does not contain financial performance data.
Material Changes
- Board Expansion: The Board of Directors expanded the number of authorized directors from ten to eleven.
- Director Election: Robert S. Field was elected as a director, effective immediately following the April 16, 2026 Annual Meeting.
- Independence Status: The Board determined Mr. Field qualifies as an independent director under New York Stock Exchange standards.
Guidance, Outlook, and Management Commentary
Compensation: Mr. Field will be compensated in accordance with the Company's director compensation program, including the grant of restricted stock units (RSUs). Details are disclosed in the proxy statement filed on March 6, 2026.
Committee Assignments: No determination has yet been made regarding Mr. Field's appointment to any Board committees.
Conflicts of Interest: The filing states there are no arrangements regarding his election and no transactions in which Mr. Field has a material interest.
Investor Verification Checklist
- Verify the full text of the press release attached as Exhibit 99.1 for additional context on Mr. Field's background.
- Review the 2026 Proxy Statement (filed March 6, 2026) for specific details on the director compensation program and RSU grant terms.
- Monitor future filings for announcements regarding Mr. Field's specific committee assignments.